Through this collaboration with Microsoft, UCB seeks to discover and develop medicines faster for people living with severe diseases in immunology and neurology Microsoft will provide AI technology ...
UCB S.A. UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback